SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000637
Filing Date
2023-04-13
Accepted
2023-04-13 16:50:03
Documents
53
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K eucr-20221231x10k.htm   iXBRL 10-K 1437428
2 EX-31.1 eucr-20221231xex31d1.htm EX-31.1 13870
3 EX-31.2 eucr-20221231xex31d2.htm EX-31.2 13702
4 EX-32.1 eucr-20221231xex32d1.htm EX-32.1 6395
5 EX-32.2 eucr-20221231xex32d2.htm EX-32.2 6449
  Complete submission text file 0001410578-23-000637.txt   5053871

Data Files

Seq Description Document Type Size
6 EX-101.SCH eucr-20221231.xsd EX-101.SCH 43485
7 EX-101.CAL eucr-20221231_cal.xml EX-101.CAL 19940
8 EX-101.DEF eucr-20221231_def.xml EX-101.DEF 174447
9 EX-101.LAB eucr-20221231_lab.xml EX-101.LAB 329826
10 EX-101.PRE eucr-20221231_pre.xml EX-101.PRE 256379
47 EXTRACTED XBRL INSTANCE DOCUMENT eucr-20221231x10k_htm.xml XML 647986
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39650 | Film No.: 23818927
SIC: 6770 Blank Checks